Global Blood Donor Screening Market, By Technology (ELISA, NAT, Western Blotting, NGS, and CLIA & EIA), By Product (Instrument, Reagent), By Region (NA, EU, APAC, LATAM, and MEA) Analysis, Share, Trends, Size, & Forecast From 2020 2026
REPORT HIGHLIGHT
The global blood donor screening market was valued at USD XX billion by 2019, growing with XX% CAGR during the forecast period, 2020-2026
Market Dynamics
A blood donor screening is a medical process that refers to different tests carried out on blood samples for conditions such as pregnancy and various diseases such as syphilis, hepatitis, and AIDS. It helps in monitoring diseases, preventing health issues as well as a variety of other conditions such as cancer and infections. Before blood donation, blood donor screening is the defense mechanism that is executed against the spread of infection. In laboratories, several blood screenings are performed before blood products or blood is transfused. Various initiatives are undertaken by governments and organizations to increase awareness amongst people regarding screening and donation before transfusion.
The rising awareness about healthcare, the growing prevalence of infectious diseases, and the increasing number of blood donors all across the globe are some of the significant factors driving the growth of the global blood donor screening market. As per WHO statistics, nearly 108 million blood donations are collected globally every year. The maximum number of blood donors are from developed countries. World Health Organization has also established a goal to provide the world with safe blood access in 2020. The non-profit organizations are also taking initiatives to volunteer blood donation campaigns. Such initiatives upsurge charitable donations and are expected to propel the market throughout the forecast. However, the dearth of skilled man force, stringent regulatory approvals, and high operating costs are some of the threats to the market growth.
Technology Takeaway
Based on technology, the global blood donor screening market is segmented into the nucleic acid amplification test, western blotting, chemiluminescence immunoassay & enzyme immunoassay, ELISA, and next-generation sequencing. Of these technologies, the NAT segment is anticipated to rise at the fastest growth rate owing to its high specificity and sensitivity for viral nucleic acid. This test is faster than other screening methods as it narrows the window period of HIV, HCV, and HBV infections. Transcription-mediated amplification, ligase chain reaction, and polymerase are some of the methods that come under this segment.
The FDA approved Roche’s next-generation donor screening test known as Cobas MPX in October 2016. At the time of blood transfusion, the Cobas MPX screening test prevents the spread of viruses. This test is used for detecting five viruses which include HCV, HBV, HIV-2, HIV-1 Group M, and HIV-1 Group O.
On the other hand, the second largest market share is estimated to be held by the ELISA segment. This is major because this technology is attributed to growing exponentially owing to its low cost than NAT, continuous development to improve specificity and the growing prevalence of infectious diseases all across the globe.
Product Takeaway
On the basis of the product, the global market is categorized into instrument & reagent. The reagent product segmented dominated the global market in 2018 and is expected to continue its dominance throughout the period of forecast. The higher specificity and accuracy of this product in detecting the presence and type of several elements in a small blood sample is likely expected to gear the market. Additionally, reagents are beneficial for market vendors owing to their high return on investment and it is also cost-effective for consumers. However, reagents’ reusable nature and high cost can hinder the market growth during the forecast period.
Along with reagents, the instrument product segment was valued at a significant share in 2018 and is predicted to generate a good market share in the projected timeframe. This is mainly because these devices are introduced in the global market only after getting marketing approval from the FDA. For instance, in October 2017, Roche received FDA approval for their Cobas Zika, a donor screening test specially designed for the Zika virus. This test is used to prevent the spread of Zika through blood transfusion.
Regional Takeaway
Geographically, the global market for blood donor screening is classified into North America, Asia Pacific, Europe, LATAM, and MEA. The North America blood donor screening market accounted for the highest market share in 2018 and is expected to generate the largest revenue by the end of 2026. The regulations of FDA for blood transfusion, presence of major industry players, greater patient affordability, and rising adoption of blood screening methods are some of the factors responsible for the growth of the market in this region.
In March 2015, a next-gen viral load assay was launched by Roche in Europe for HBV. This is a quantitative nucleic acid test namely COBAS HBV, which is used for COBAS 8800/6800 Systems. Thus, the adoption and development of such novel technologies are further anticipated to boost the market in the Europe region.
Furthermore, the Asia Pacific blood donor screening market is anticipated to be the fastest mounting region owing to the growing awareness of people regarding blood transfusion and the increasing focus of prominent players of the industry on emerging economies in this region. India, China, Australia, Japan, and Singapore are major contributing countries in these regions.
Key Vendor Takeaway
Some of the prominent players of the global industry include Thermo Fisher Scientific., Becton Dickinson & Company, Ortho-Clinical Diagnostics, Inc., Danaher Corporation (Beckman Coulter), Grifols, Bio-Rad Laboratories, Inc., Abbott Laboratories; Siemens AG, and F. Hoffmann-La Roche Ltd. These players are adopting several strategies such as product development, mergers & acquisitions, partnerships, and collaborations to hold a strong position in the global industry.
For instance, in September 2016, Siemens Healthineers acquired Germany-based Conworx Technology GmbH for data management solutions and point of care device interfaces. The solutions and products of the company are specially designed to aid in growing efficiency and to decreased costs.
The market size and forecast for each segment and sub-segments has been considered as below:
- Historical Year – 2015 to 2018
- Base Year – 2019
- Estimated Year – 2020
- Projected Year – 2026
TARGET AUDIENCE
- Traders, Distributors, and Suppliers
- Manufacturers
- Government and Regional Agencies
- Research Organizations
- Consultants
- Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
KEY PLAYERS
- Thermo Fisher Scientific.
- Becton Dickinson & Company
- Ortho-Clinical Diagnostics, Inc.
- Danaher Corporation (Beckman Coulter)
- Grifols
- Bio-Rad Laboratories, Inc.
- Abbott Laboratories
- Siemens AG
- Hoffmann-La Roche Ltd.
MARKET BY TECHNOLOGY
- Western Blotting
- Nucleic Acid Amplification Test (NAT)
- Chemiluminescence Immunoassay (CLIA) & Enzyme Immunoassay (EIA)
- ELISA
- Next-Generation Sequencing (NGS)
MARKET BY PRODUCT
- Instrument
- Reagent
MARKET BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Singapore
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Rest of MEA
TABLE OF CONTENT
1. GLOBAL BLOOD DONOR SCREENING MARKET OVERVIEW
1.1. Study Scope
1.2. Assumption and Methodology
2. EXECUTIVE SUMMARY
2.1. Market Snippet
2.1.1. Market Snippet by Technology
2.1.2. Market Snippet by Product
2.1.3. Market Snippet by Region
2.2. Competitive Insights
3. GLOBAL BLOOD DONOR SCREENING KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. GLOBAL BLOOD DONOR SCREENING INDUSTRY STUDY
4.1. Porter’s Five Forces Analysis
4.2. Marketing Strategy Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. GLOBAL BLOOD DONOR SCREENING MARKET LANDSCAPE
5.1. Market Share Analysis
5.2. Key Innovators
5.3. Breakdown Data, by Key manufacturer
5.3.1. Established Player Analysis
5.3.2. Emerging Player Analysis
6. GLOBAL BLOOD DONOR SCREENING MARKET – BY TECHNOLOGY
6.1. Overview
6.1.1. Segment Share Analysis, By Technology, 2019 & 2026 (%)
6.2. Western Blotting
6.2.1. Overview
6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.3. Nucleic Acid Amplification Test (NAT)
6.3.1. Overview
6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.4. Chemiluminescence Immunoassay (CLIA) & Enzyme Immunoassay (EIA)
6.4.1. Overview
6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.5. ELISA
6.5.1. Overview
6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.6. Next-Generation Sequencing (NGS)
6.6.1. Overview
6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7. GLOBAL BLOOD DONOR SCREENING MARKET – BY PRODUCT
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2019 & 2026 (%)
7.2. Instrument
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.3. Reagent
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8. GLOBAL BLOOD DONOR SCREENING MARKET– BY GEOGRAPHY
8.1. Introduction
8.1.1. Segment Share Analysis, By Region, 2019 & 2026 (%)
8.2. North America
8.2.1. Overview
8.2.2. Key Manufacturers in North America
8.2.3. North America Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
8.2.4. North America Market Size and Forecast, By Technology, 2015 – 2026 (US$ Million)
8.2.5. North America Market Size and Forecast, By Product, 2015 – 2026 (US$ Million)
8.2.6. U.S.
8.2.6.1. Overview
8.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.2.7. Canada
8.2.7.1. Overview
8.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.3. Europe
8.3.1. Overview
8.3.2. Key Manufacturers in Europe
8.3.3. Europe Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
8.3.4. Europe Market Size and Forecast, By Technology, 2015 – 2026 (US$ Million)
8.3.5. Europe Market Size and Forecast, By Product, 2015 – 2026 (US$ Million)
8.3.6. Germany
8.3.6.1. Overview
8.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.3.7. Italy
8.3.7.1. Overview
8.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.3.8. United Kingdom
8.3.8.1. Overview
8.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.3.9. France
8.3.9.1. Overview
8.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.3.10. Rest of Europe
8.3.10.1. Overview
8.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.4. Asia Pacific (APAC)
8.4.1. Overview
8.4.2. Key Manufacturers in Asia Pacific
8.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
8.4.4. Asia Pacific Market Size and Forecast, By Technology, 2015 – 2026 (US$ Million)
8.4.5. Asia Pacific Market Size and Forecast, By Product, 2015 – 2026 (US$ Million)
8.4.6. India
8.4.6.1. Overview
8.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.4.7. China
8.4.7.1. Overview
8.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.4.8. Japan
8.4.8.1. Overview
8.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.4.9. South Korea
8.4.9.1. Overview
8.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.4.10. Rest of APAC
8.4.10.1. Overview
8.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.5. Latin America
8.5.1. Overview
8.5.2. Key Manufacturers in Latin America
8.5.3. Latin America Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
8.5.4. Latin America Market Size and Forecast, By Technology 2015 – 2026 (US$ Million)
8.5.5. Latin America Market Size and Forecast, By Product, 2015 – 2026 (US$ Million)
8.5.6. Brazil
8.5.6.1. Overview
8.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.5.7. Mexico
8.5.7.1. Overview
8.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.5.8. Argentina
8.5.8.1. Overview
8.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.5.9. Rest of LATAM
8.5.9.1. Overview
8.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.6. Middle East and Africa
8.6.1. Overview
8.6.2. Key Manufacturers in Middle East and Africa
8.6.3. Middle East and Africa Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
8.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2015 – 2026 (US$ Million)
8.6.5. Middle East and Africa Market Size and Forecast, By Product, 2015 – 2026 (US$ Million)
8.6.6. Saudi Arabia
8.6.6.1. Overview
8.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.6.7. United Arab Emirates
8.6.7.1. Overview
8.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9. KEY VENDOR ANALYSIS
9.1. Thermo Fisher Scientific.
9.1.1. Company Snapshot
9.1.2. Financial Performance
9.1.3. Product Benchmarking
9.1.4. Strategic Initiatives
9.2. Becton Dickinson & Company
9.3. Ortho-Clinical Diagnostics, Inc.
9.4. Danaher Corporation (Beckman Coulter)
9.5. Grifols
9.6. Bio-Rad Laboratories, Inc.
9.7. Abbott Laboratories
9.8. Siemens AG
9.9. L. Hoffmann-La Roche Ltd.
10. 360 DEGREE ANALYSTVIEW
11. APPENDIX
11.1. Research Methodology
11.2. References
11.3. Abbreviations
11.4. Disclaimer
11.5. Contact Us
List of Tables
TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Global Blood Donor Screening market: Technology Snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Technology
TABLE Global Blood Donor Screening market, by Technology 2015-2026 (USD Million)
TABLE Global Blood Donor Screening market: Product Snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Product
TABLE Global Blood Donor Screening market, by Product 2015-2026 (USD Million)
TABLE Global Blood Donor Screening market: Regional snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Blood Donor Screening market, by Region 2015-2026 (USD Million)
TABLE North America Blood Donor Screening market, by Country, 2015-2026 (USD Million)
TABLE North America Blood Donor Screening market, by Technology, 2015-2026 (USD Million)
TABLE North America Blood Donor Screening market, by Product, 2015-2026 (USD Million)
TABLE Europe Blood Donor Screening market, by country, 2015-2026 (USD Million)
TABLE Europe Blood Donor Screening market, by Technology, 2015-2026 (USD Million)
TABLE Europe Blood Donor Screening market, by Product, 2015-2026 (USD Million)
TABLE Asia Pacific Blood Donor Screening market, by Country, 2015-2026 (USD Million)
TABLE Asia Pacific Blood Donor Screening market, by Technology, 2015-2026 (USD Million)
TABLE Asia Pacific Blood Donor Screening market, by Product, 2015-2026 (USD Million)
TABLE Latin America Blood Donor Screening market, by Country, 2015-2026 (USD Million)
TABLE Latin America Blood Donor Screening market, by Technology, 2015-2026 (USD Million)
TABLE Latin America Blood Donor Screening market, by Product, 2015-2026 (USD Million)
TABLE Middle East and Africa Blood Donor Screening market, by Country, 2015-2026 (USD Million)
TABLE Middle East and Africa Blood Donor Screening market, by Technology, 2015-2026 (USD Million)
TABLE Middle East and Africa Blood Donor Screening market, by Product, 2015-2026 (USD Million)
List of Figures
FIGURE Global Blood Donor Screening market segmentation
FIGURE Market research methodology
FIGURE Value chain analysis
FIGURE Porter’s Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE Competitive Landscape; Key company market share analysis, 2018
FIGURE Technology segment market share analysis, 2019 & 2026
FIGURE Technology segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Western Blotting market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Nucleic Acid Amplification Test (NAT) market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Chemiluminescence Immunoassay (CLIA) & Enzyme Immunoassay (EIA) market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE ELISA market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Next-Generation Sequencing (NGS) market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Product segment market share analysis, 2019 & 2026
FIGURE Product segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Instrument market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Reagent market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Regional segment market share analysis, 2019 & 2026
FIGURE Regional segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE North America Blood Donor Screening market share and leading players, 2018
FIGURE Europe Blood Donor Screening market share and leading players, 2018
FIGURE Asia Pacific Blood Donor Screening market share and leading players, 2018
FIGURE Latin America Blood Donor Screening market share and leading players, 2018
FIGURE Middle East and Africa Blood Donor Screening market share and leading players, 2018
FIGURE North America Blood Donor Screening market share analysis by Country, 2018
FIGURE U.S. Blood Donor Screening market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Canada Blood Donor Screening market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Europe Blood Donor Screening market share analysis by Country, 2018
FIGURE Germany Blood Donor Screening market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Spain Blood Donor Screening market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Italy Blood Donor Screening market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE UK Blood Donor Screening market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE France Blood Donor Screening market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Rest of the Europe Blood Donor Screening market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Asia Pacific Blood Donor Screening market share analysis by Country, 2018
FIGURE India Blood Donor Screening market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE China Blood Donor Screening market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Japan Blood Donor Screening market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE South Korea Blood Donor Screening market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Singapore Blood Donor Screening market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Rest of APAC Blood Donor Screening market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Latin America Blood Donor Screening market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Latin America Blood Donor Screening market share analysis by Country, 2018
FIGURE Brazil Blood Donor Screening market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Mexico Blood Donor Screening market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Argentina Blood Donor Screening market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Rest of LATAM Blood Donor Screening market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Middle East and Africa Blood Donor Screening market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Middle East and Africa Blood Donor Screening market share analysis by Country, 2018
FIGURE Saudi Arabia Blood Donor Screening market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE United Arab Emirates Blood Donor Screening market size, forecast and trend analysis, 2015 to 2026 (USD Million)
